Bonaventura Clotet to Lamivudine
This is a "connection" page, showing publications Bonaventura Clotet has written about Lamivudine.
Connection Strength
0.163
-
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial. J Antimicrob Chemother. 2018 07 01; 73(7):1965-1971.
Score: 0.163